Additionally, population-level differences in pathophysiological mechanisms, such as variation in insulin resistance, beta cell function, fat distribution and the prevalence of specific diabetes subtypes, may influence how individuals respond to metabolic improvements [35]. The gene discussed is INS; the disease is diabetes mellitus.